Literature DB >> 12519374

Very low incidence of microsatellite instability in rectal cancers from families at risk for HNPCC.

N Hoogerbrugge1, R Willems, H J Van Krieken, L A Kiemeney, M Weijmans, F M Nagengast, N Arts, H G Brunner, M J L Ligtenberg.   

Abstract

In families at risk for hereditary non-polyposis colorectal cancer (HNPCC) that do not fulfill all clinical criteria for HNPCC, additional evidence is sought by testing cancer specimens for microsatellite instability (MSI). We investigated whether the location of a colorectal cancer (CRC) predicts the result of MSI-testing in these families. One hundred and seven patients suspected for HNPCC were offered MSI-testing. MSI-testing was positive in 6/7 patients with endometrial carcinoma and in 22/100 patients with CRC. Only one out of 22 (4%) rectal cancers was MSI-positive, and in this patient no mismatch repair (MMR) gene mutation was found. Right-sided colon carcinomas were more likely to be MSI-positive (14/37 or 38%), followed by left-sided colon carcinomas (7/4 or 17%) (p < 0.05), with 6/14 and 4/7 MMR gene mutations, respectively. The likelihood that a tumor would be MSI-positive was 3.3 times greater for right-sided than for left-sided colon cancer (OR 3.3, p < 0.05). Microsatellite instability was 8.1 times more frequent in colon cancers than in rectal cancers (p < 0.05). The presence of MSI was independently related to fulfillment of the Bethesda criteria (OR 7.0, p = 0.01). In families with multiple cases of colorectal cancer, the rectal cancers are only rarely MSI-positive. This indicates that even in families with multiple colorectal cancers, rectal cancers are most commonly of sporadic origin.

Entities:  

Mesh:

Year:  2003        PMID: 12519374     DOI: 10.1034/j.1399-0004.2003.630110.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  6 in total

Review 1.  Clinical implications of microsatellite instability in sporadic colon cancers.

Authors:  Frank A Sinicrope; Daniel J Sargent
Journal:  Curr Opin Oncol       Date:  2009-07       Impact factor: 3.645

2.  Compound heterozygosity for two MSH2 mutations suggests mild consequences of the initiation codon variant c.1A>G of MSH2.

Authors:  Carolien M Kets; Nicoline Hoogerbrugge; Joannes H J M van Krieken; Monique Goossens; Han G Brunner; Marjolijn J L Ligtenberg
Journal:  Eur J Hum Genet       Date:  2008-09-10       Impact factor: 4.246

3.  Clinical utility of KRAS and BRAF mutations in a cohort of patients with colorectal neoplasms submitted for microsatellite instability testing.

Authors:  Allison M Cushman-Vokoun; Daniel G Stover; Zhiguo Zhao; Elizabeth A Koehler; Jordan D Berlin; Cindy L Vnencak-Jones
Journal:  Clin Colorectal Cancer       Date:  2013-06-14       Impact factor: 4.481

4.  Very low prevalence of germline MSH6 mutations in hereditary non-polyposis colorectal cancer suspected patients with colorectal cancer without microsatellite instability.

Authors:  C M Kets; J H J M van Krieken; K M Hebeda; S J Wezenberg; M Goossens; H G Brunner; M J L Ligtenberg; N Hoogerbrugge
Journal:  Br J Cancer       Date:  2006-11-21       Impact factor: 7.640

5.  Muir Torre syndrome and MSH2 mutations: the importance of dermatological awareness.

Authors:  M Tischkowitz; A Gologan; H Srolovitz; M Khanna; W D Foulkes
Journal:  Br J Cancer       Date:  2006-06-20       Impact factor: 7.640

6.  Patients with an unexplained microsatellite instable tumour have a low risk of familial cancer.

Authors:  L I H Overbeek; C M Kets; K M Hebeda; D Bodmer; E van der Looij; R Willems; M Goossens; N Arts; H G Brunner; J H J M van Krieken; N Hoogerbrugge; M J L Ligtenberg
Journal:  Br J Cancer       Date:  2007-04-24       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.